Medicare expands pool of BMM patients, but reduces fee

Why This Topic Matters

The update affects which patients may qualify for covered osteoporosis testing, how claims are submitted, and which billed services may be denied or paid differently under Medicare. It is relevant for avoiding claim errors and understanding the policy basis for BMM billing.

Article Sections

1. Policy update and effective date

   Introduces the Medicare revision to bone mass measurement coverage and notes when the change was implemented and made effective. It also identifies the policy source referenced in the article.

2. Eligibility change for steroid therapy patients

   Summarizes the broad change to patient eligibility for bone mass measurement under steroid therapy monitoring. The section focuses on the coverage criteria update without detailing the underlying decision logic.

3. Code change and payment impact

   Describes the coding and reimbursement changes associated with the service under Medicare. It notes the article’s discussion of the billing change and payment reduction.

4. Diagnosis code requirements

   Reviews the diagnosis-code categories associated with the procedure under Medicare guidance. The section places the codes in the context of condition support for the service.

5. Denials warning and modifier guidance

   Covers the article’s discussion of related tests that may be denied and the claim-processing note involving beneficiary notice documentation. It also identifies the modifier mentioned in that context.